Shape 21 Experience
    Shape 21 Experience
      1. Home
      2. Stroke

      siemens-healthineers_events_rsna_highlight-topic_breast-cancer

      Stroke

      In stroke management, latest studies showed that the time window for mechanical thrombectomy is open up to 24 hours. This improves stroke treatment for a larger part of the 15 million people suffering a stroke each year1. For you, however, it means that stroke care turns into a double challenge: Besides having to treat each stroke patient as fast as possible, you also have to be ready to treat more patients.
      Advance therapy outcomes with our comprehensive stroke solution ARTIS icono, providing time resolved collateral vessel and intracranial bleeding visualization in the angio lab.

      From stroke to soccer in just one week

      See how precision imaging with optimal image quality and sharp images of small moving objects, coupled with an optimally adapted in-hospital stroke workflow allowed a young stroke sufferer to go on as if nothing had happened.

      Find out more about our portfolio for advanced stroke treatment

      ARTIS icono biplan

      ARTIS icono biplane2

      Advance therapy outcomes with our groundbreaking solution ARTIS icono.

      CT SOMATOM X.cite

      SOMATOM X.cite2

      Intelligent imaging. Excellence empowered.

      SOMATOM On.Site

      SOMATOM On.site3

      Bringing critical care imaging to your patient.

      MAGNETOM Free.Max

      MAGNETOM Free.Max4

      MAGNETOM Free.Max is designed to break barriers and expand the reach of MRI.

      Join us for our talks on stroke management

      1

      www.strokecenter.org

      2

      The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.

      3

      This product does not yet fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations neither all applicable General Safety and Performance Requirements according to the European Medical Device Regulation 2017/745. It is not yet commercially available and its future availability cannot be ensured.

      4

      The product is still under development and not commercially available yet. Its future availability cannot be ensured.